Literature DB >> 12928248

Biological variation of N-terminal pro-brain natriuretic peptide in healthy individuals.

GianVico Melzi d'Eril, Tiziana Tagnochetti, Andrea Nauti, Catherine Klersy, Antonia Papalia, Giovanbattista Vadacca, Remigio Moratti, Giampaolo Merlini.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 12928248     DOI： 10.1373/49.9.1554

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  12 in total

1.  Uncertainty of measurement: what it is and what it should be.

Authors:  Tony Badrick; Robert C Hawkins; Susan R Wilson; Peter E Hickman
Journal:  Clin Biochem Rev       Date:  2005-11

Review 2.  Biological and analytical variation of clinical biomarker testing: implications for biomarker-guided therapy.

Authors:  Alan H B Wu
Journal:  Curr Heart Fail Rep       Date:  2013-12

3.  Reference limits for N-terminal-pro-B-type natriuretic peptide in healthy individuals (from the Framingham Heart Study).

Authors:  Michael G Fradley; Martin G Larson; Susan Cheng; Elizabeth McCabe; Erin Coglianese; Ravi V Shah; Daniel Levy; Ramachandran S Vasan; Thomas J Wang
Journal:  Am J Cardiol       Date:  2011-08-23       Impact factor: 2.778

4.  Variability of NT-proBNP plasma and urine levels in patients with stable heart failure: a 2-year follow-up study.

Authors:  Raquel Cortés; Miguel Rivera; Antonio Salvador; Vicente Bertomeu; Fernando García de Burgos; Esther Roselló-Lletí; Manuel Portolés; Rafael Payá; Luis Martínez-Dolz; Vicente Climent
Journal:  Heart       Date:  2007-05-08       Impact factor: 5.994

5.  Combined determination of B-type natriuretic peptide and high-sensitivity troponin I in the postmortem diagnosis of cardiac disease.

Authors:  Rafael Bañón; Diana Hernández-Romero; Esperanza Navarro; María Dolores Pérez-Cárceles; José Antonio Noguera-Velasco; Eduardo Osuna
Journal:  Forensic Sci Med Pathol       Date:  2019-08-30       Impact factor: 2.007

6.  Evaluation of postmortem measurement of NT-proBNP as a marker for cardiac function.

Authors:  Katarzyna Michaud; Marc Augsburger; Nicolas Donzé; Sara Sabatasso; Mohamed Faouzi; Marc Bollmann; Patrice Mangin
Journal:  Int J Legal Med       Date:  2008-06-14       Impact factor: 2.686

7.  Variability of NT-proBNP and its relationship with inflammatory status in patients with stable essential hypertension: a 2-year follow-up study.

Authors:  Esther Roselló-Lletí; Jose R Calabuig; Pedro Morillas; Raquel Cortés; Luis Martínez-Dolz; Luis Almenar; Jose R González-Juanatey; Catheline Lauwers; Antonio Salvador; Manuel Portolés; Vicente Bertomeu; Miguel Rivera
Journal:  PLoS One       Date:  2012-02-23       Impact factor: 3.240

Review 8.  Rationale, application and clinical qualification for NT-proBNP as a surrogate end point in pivotal clinical trials in patients with AL amyloidosis.

Authors:  G Merlini; I Lousada; Y Ando; A Dispenzieri; M A Gertz; M Grogan; M S Maurer; V Sanchorawala; A Wechalekar; G Palladini; R L Comenzo
Journal:  Leukemia       Date:  2016-07-15       Impact factor: 11.528

9.  Variability of biomarkers in patients with chronic heart failure and healthy controls.

Authors:  Wouter C Meijers; A Rogier van der Velde; Anneke C Muller Kobold; Janneke Dijck-Brouwer; Alan H Wu; Allan Jaffe; Rudolf A de Boer
Journal:  Eur J Heart Fail       Date:  2016-10-21       Impact factor: 15.534

10.  The biological variation of N-terminal pro-brain natriuretic peptide in postmenopausal women with type 2 diabetes: a case control study.

Authors:  Susana González; Eric S Kilpatrick; Stephen L Atkin
Journal:  PLoS One       Date:  2012-11-09       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.